Key result
Nitric oxide-mediated vasodilator mechanisms were not impaired in hypertensive transgenic ((mRen-2)27) rats compared to normotensive rats.
Population
Conscious, hypertensive, transgenic (27) rats and normotensive, Hannover Sprague-Dawley rats
Comparison
Administration of vasodilators and NO synthase… vs Normotensive Hannover Sprague-Dawley rats…
Design
Preclinical
Authors
Loading...
Does not implicate NO impairment in this hypertensive rat model; leaves open beta2-adrenoceptor mechanisms for human hypertension research.
There is no direct evidence for impaired NO-mediated vasodilator mechanisms in hypertensive transgenic ((mRen-2)27) rats, suggesting altered responses may involve abnormal beta2-adrenoceptor-mediated processes.
Gardiner et al. (1998) studied Hypertension. Vasodilators and NO synthase inhibition vs. Normotensive Hannover Sprague-Dawley (SD) rats was evaluated on Regional haemodynamic responses to vasodilators and effects of NO synthase inhibition. Nitric oxide-mediated vasodilator mechanisms were not impaired in hypertensive transgenic ((mRen-2)27) rats compared to normotensive rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: